|
|
 |
|
Viewing report
|
|
|
|
Alzheimer’s - Treatment, Symptoms and Management
GlobalData, Nov 2010, Pages: 97
Alzheimer's disease (AD), also called Alzheimer disease, Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer's, is the most common form of dementia. This incurable, degenerative, and terminal disease was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him. Generally it is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer's can occur much earlier. An estimated 26.6 million people worldwide had Alzheimer's in 2006; this number may quadruple by 2050.
As many as 5.3 million Americans are living with Alzheimer’s disease. Alzheimer's destroys brain cells, causing problems with memory, thinking and behavior severe enough to affect work, lifelong hobbies or social life. Alzheimer’s gets worse over time, and it is fatal. Today it is the seventh-leading cause of death in the United States.
This report examines Alzheimer’s Disease, its treatment, the symptoms, managing of Alzheimer’s, AD in adults, and the genetic component behind Alzheimer’s.
Customers who bought this item also bought
Alzheimer Disease - New Drugs, Markets and Companies
Research Report on Chinese Anti Senile Dementia Drug Market, 2010-2011
Emerging Drug Targets in Alzheimer's Disease
Advances in Alzheimer’s Disease Drug Discovery
Alzheimer's Disease Autoantibodies, Vaccines and Therapeutic Antibodies Pipeline, 2011
Dementia: Causes, Treatments, and Outlook 2011
Alzheimer's Disease: Competing Treatments and Market Entry Considerations
Dementia: An Atlas of Investigation and Diagnosis
U.S. Alzheimer's Disease Medication Markets
The 10th International Conference on Alzheimer's and Parkinson's Diseases: Post-Conference Review and Analysis
|
|
|
|
